DO I UNDERSTAND CORRECTLY?
The proposed CEO under Plan A who is very well respected in the industry, who holds a senior position with a MAJOR pharma company is willing to leave that job for a floundering company like Provectus? Could it be for a huge increase in salary? Could it be for incredible befenits? Could it be for improved working conditions? Or could it be that the ultimate goal of Plan A is to bankrupt the current company, seize the IP and start a totally new private company owned by Peter, the CEO and his BOD. That would offer a potentially huge windfall far more than any money that could be had by working for a big pharma. Kinda makes a lot of sense, at least to me, but then again, what the fu-k do I know?
Starlight,
I agree it is important to evaluate all sides, as we the jury, choose a side.
A few of my thoughts to share with you, fwiw.
I think it is worth knowing the age & heart of a CEO, as we all try to evaluate what is their ultimate goal.
As humans age, we tend to become more interested in leaving a legacy, rather than just gain more resume points or money.
And to quote, .....all that is essential is invisible to the eye (the heart)
To this end, below is one of my favorite paragraphs from the interview with Plan A's proposed CEO. All jury's eventually must decide if they believe a person or not. This paragraph has never left my mind and heart:
Alan, this happens to be one of my favorite questions so thanks for asking it. I have been following Provectus for several years and believe that with the right management and strategy that PV-10 could be an excellent and broadly used agent to treat cancer. I have extensively studied the science behind PV-10 and I believe that I can make the drug successful if given the opportunity. The other part of this answer is more of an emotional one for me. Having been in the cancer field for some time, I know that many cancer patients on their death beds have volunteered to be part of clinical trials for PV-10, knowing well that they were doing this to pave the way for future cancer patients to receive better treatment. It is a injustice to those patients that those in control of the company have not managed the business well, and patients remain wanting for this valuable therapeutic approach. I am here to change that.